These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2765169)

  • 1. Blockade of the nootropic action of piracetam-like nootropics by adrenalectomy: an effect of dosage?
    Mondadori C; Ducret T; Petschke F
    Behav Brain Res; 1989 Aug; 34(1-2):155-8. PubMed ID: 2765169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The memory-enhancing effects of the piracetam-like nootropics are dependent on experimental parameters.
    Mondadori C; Ducret T; Borkowski J
    Behav Brain Res; 1989 May; 33(1):79-82. PubMed ID: 2736062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of a steroidal component in the mechanism of action of piracetam-like nootropics.
    Mondadori C; Bhatnagar A; Borkowski J; Häusler A
    Brain Res; 1990 Jan; 506(1):101-8. PubMed ID: 2137359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new one-trial test for neurobiological studies of memory in rats. II: Effects of piracetam and pramiracetam.
    Ennaceur A; Cavoy A; Costa JC; Delacour J
    Behav Brain Res; 1989 Jun; 33(2):197-207. PubMed ID: 2765166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oxiracetam on learning and memory in animals: comparison with piracetam.
    Mondadori C; Classen W; Borkowski J; Ducret T; Buerki H; Schadé A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S27-38. PubMed ID: 3594453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoidance facilitation by nootropics.
    Sansone M; Oliverio A
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S89-97. PubMed ID: 2616794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitating effect of oxiracetam and piracetam on acquisition of discrete two-way shuttle avoidance in normal mice.
    Kuribara H; Tadokoro S
    Jpn J Pharmacol; 1988 Dec; 48(4):494-8. PubMed ID: 3244203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement by oxiracetam of passive avoidance improvement induced by the presynaptic muscarinic antagonist secoverine in mice.
    Ammassari-Teule M; Castellano C; Sansone M
    Behav Brain Res; 1992 Mar; 47(1):93-5. PubMed ID: 1571105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nootropic drugs on brain cholinergic and dopaminergic transmission.
    Pavlík A; Benesová O; Dlohozková N
    Act Nerv Super (Praha); 1987 Mar; 29(1):62-5. PubMed ID: 3035858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of scopolamine-induced alterations of choline transport across the blood-brain barrier by the nootropics piracetam and pramiracetam.
    Brust P
    Arzneimittelforschung; 1989 Oct; 39(10):1220-2. PubMed ID: 2610714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of aniracetam (Ro 13-5057) on the enhancement and protection of memory.
    Vincent G; Verderese A; Gamzu E
    Ann N Y Acad Sci; 1985; 444():489-91. PubMed ID: 3860106
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a cholinergic nootropic (WEB 1881 FU) on event-related potentials recorded in incidental and intentional memory tasks.
    Münte TF; Heinze HJ; Scholz M; Künkel H
    Neuropsychobiology; 1988; 19(3):158-68. PubMed ID: 3059222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nootropics on memory: new aspects for basic research.
    Mondadori C; Petschke F; Häusler A
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():102-6. PubMed ID: 2690149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do piracetam-like compounds act centrally via peripheral mechanisms?
    Mondadori C; Petschke F
    Brain Res; 1987 Dec; 435(1-2):310-4. PubMed ID: 3427459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of the nootropic properties of piracetam and oxiracetam].
    Krylova IN; Antonova LV; Kamenskiĭ AA; Iasnetsov VV
    Farmakol Toksikol; 1991; 54(1):14-6. PubMed ID: 1860490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nootropic drugs and aging.
    Giurgea CE; Greindl MG; Preat S
    Acta Psychiatr Belg; 1983; 83(4):349-58. PubMed ID: 6660010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of piracetam to facilitate acquisition or retention in younger or older rats.
    Means LW; Franklin RD; Cliett CE
    Exp Aging Res; 1980 Apr; 6(2):175-80. PubMed ID: 7389786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arousal deficit shown in aged rat's quantitative EEG and ameliorative action of pramiracetam compared to piracetam.
    Poschel BP; Ho PM; Ninteman FW
    Experientia; 1985 Nov; 41(11):1433-5. PubMed ID: 4065299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice.
    Rashid MH; Ueda H
    J Pharmacol Exp Ther; 2002 Oct; 303(1):226-31. PubMed ID: 12235255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative electrophysiological investigations on oxiracetam and piracetam.
    Olpe HR; Pozza MF; Jones RS; Haas HL
    Clin Neuropharmacol; 1986; 9 Suppl 3():S48-55. PubMed ID: 3594456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.